ClinConnect ClinConnect Logo
Search / Trial NCT06530992

The Effect of Tucking on Semen Quality of Adult Trans Women

Launched by MEDICAL UNIVERSITY INNSBRUCK · Jul 29, 2024

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how a practice called tucking, which some transgender women use to minimize bulging in their groin area, might affect their sperm quality. The researchers want to understand if tucking or wearing tight underwear contributes to lower sperm quality even before starting hormone therapy, which is known to potentially impact fertility. The study will include 40 transgender women aged 18 to 50 who are preparing to start hormone therapy. Half of them will be those who practice tucking, while the other half will not.

Participants can expect to provide semen and blood samples to assess their sperm quality and overall health at the beginning of the study. After a period of abstaining from tucking, they will provide more samples to see if there are any changes. Additionally, they will have the option to preserve their sperm for future use if they wish. This study is important because it aims to clarify the relationship between tucking and sperm quality, helping transgender women make informed choices about their fertility before starting hormone therapy.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Female transgender patients between the ages of 18 to 50 years of age who are seen at the University Clinic for Gyn. Endocrinology and Reproductive Medicine of the Medical University of Innsbruck. Patients must have met the eligibility and readiness criteria for gender-affirming hormone therapy
  • Exclusion Criteria:
  • Ongoing GAHT gender affirming genital surgery Hypogonadism Diabetes mellitus Cystic Fibrosis Varicocele Cryptorchism Post-sterilization Incapacity to consent

About Medical University Innsbruck

The Medical University of Innsbruck is a leading academic institution dedicated to advancing healthcare through innovative research and clinical excellence. Situated in the heart of the Austrian Alps, it combines a rich tradition of medical education with cutting-edge scientific inquiry. As a prominent sponsor of clinical trials, the university focuses on a broad spectrum of medical fields, emphasizing the translation of research findings into practical applications for patient care. With a commitment to ethical standards and rigorous methodologies, the Medical University of Innsbruck strives to enhance treatment options and improve health outcomes globally through its collaborative efforts in clinical research.

Locations

Innsbruck, , Austria

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported